Vaccines and autoimmunity during the COVID-19 pandemic  

作　　者：Tsvetelina Velikova 

机构地区：[1]Department of Clinical Immunology,University Hospital Lozenetz,Sofia 1407,Bulgaria [2]Medical Faculty,Sofia University,Sofia 1407,Bulgaria

出　　处：《World Journal of Immunology》2022年第2期9-14,共6页世界免疫学杂志

摘　　要：To control the pandemic,efficient vaccines must be applied to the population,including patients with autoimmune diseases.Therefore,one can expect that coronavirus disease 2019(COVID-19)vaccines may influence the underlying autoimmune processes in these patients.Additionally,it is essential to understand whether COVID-19 vaccines would be effective,safe,and provide long-lasting immunological protection and memory.However,the currently available and approved COVID-19 vaccines turned out to be safe,effective,and reliable in patients with autoimmune inflammatory and rheumatic diseases.Furthermore,most patients said they felt safer after getting vaccinations for COVID-19 and reported enhanced overall quality of life and psychological wellbeing.In general,the COVID-19 vaccines have been highly tolerated by autoimmune patients.Such findings might comfort patients who are reluctant to use COVID-19 vaccines and assist doctors in guiding their patients into receiving vaccinations more easily and quickly.

关 键 词：SARS-CoV-2 COVID-19 Immune response COVID-19 vaccine Immune memory AUTOIMMUNITY Autoimmune diseases RELAPSE 

分 类 号：R73[医药卫生—肿瘤]